NDC 0573-2621

ALAVERT ALLERGY

Loratadine

ALAVERT ALLERGY is a Oral Tablet, Orally Disintegrating in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Loratadine.

Product ID0573-2621_1ad9e626-55ca-4d43-b5ec-cc4d5bf19b07
NDC0573-2621
Product TypeHuman Otc Drug
Proprietary NameALAVERT ALLERGY
Generic NameLoratadine
Dosage FormTablet, Orally Disintegrating
Route of AdministrationORAL
Marketing Start Date2002-12-19
Marketing CategoryNDA / NDA
Application NumberNDA021375
Labeler NameGlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Substance NameLORATADINE
Active Ingredient Strength10 mg/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0573-2621-13

12 BLISTER PACK in 1 CARTON (0573-2621-13) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Marketing Start Date2016-12-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0573-2621-72 [00573262172]

ALAVERT ALLERGY TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA021375
Product TypeHUMAN OTC DRUG
Marketing Start Date2002-12-19
Marketing End Date2011-08-17

NDC 0573-2621-48 [00573262148]

ALAVERT ALLERGY TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA021375
Product TypeHUMAN OTC DRUG
Marketing Start Date2002-12-19
Marketing End Date2011-08-17

NDC 0573-2621-13 [00573262113]

ALAVERT ALLERGY TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA021375
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-12-19

NDC 0573-2621-19 [00573262119]

ALAVERT ALLERGY TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA021375
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2002-12-19

NDC 0573-2621-65 [00573262165]

ALAVERT ALLERGY TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA021375
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2002-12-19

NDC 0573-2621-12 [00573262112]

ALAVERT ALLERGY TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA021375
Product TypeHUMAN OTC DRUG
Marketing Start Date2002-12-19
Marketing End Date2011-08-17

NDC 0573-2621-18 [00573262118]

ALAVERT ALLERGY TABLET, ORALLY DISINTEGRATING
Marketing CategoryNDA
Application NumberNDA021375
Product TypeHUMAN OTC DRUG
Marketing Start Date2002-12-19
Marketing End Date2011-08-17

Drug Details

Active Ingredients

IngredientStrength
LORATADINE10 mg/1

OpenFDA Data

SPL SET ID:f45af3e4-5dd5-ea0a-c47c-8d68a1249158
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 311373
  • 351855
  • UPC Code
  • 0305732620244
  • NDC Crossover Matching brand name "ALAVERT ALLERGY" or generic name "Loratadine"

    NDCBrand NameGeneric Name
    0573-2621ALAVERT ALLERGYALAVERT ALLERGY
    0573-2620ALAVERT ALLERGYALAVERT ALLERGY
    0363-1612allergy reliefLoratadine
    0113-7612Basic Care allergy reliefLoratadine
    0113-7500basic care childrens allergy reliefloratadine
    0113-7671Basic Care Childrens Allergy ReliefLoratadine
    0121-0849Childrens LoratadineLORATADINE
    0363-2131Childrens LoratadineLoratadine
    0363-4020CHILDRENS LORATADINE ODTLoratadine
    0363-2092Childrens Wal-itinLoratadine
    0363-2108Childrens WalitinLoratadine
    0113-0612good sense allergy reliefLoratadine
    0113-1191good sense allergy reliefloratadine
    0113-1612good sense allergy reliefLoratadine
    0113-9755good sense allergy reliefloratadine
    0113-0671Good Sense childrens allergy reliefLoratadine
    0113-1019good sense childrens allergy reliefloratadine
    0113-1719good sense childrens allergy reliefLoratadine
    0363-0858Indoor Outdoor Allergy ReliefLoratadine
    0179-8317LoratadineLoratadine
    0363-0522LoratadineLoratadine
    0363-0527LoratadineLoratadine
    0363-0752LoratadineLoratadine
    0363-9603LoratadineLoratadine
    0363-0699Wal itinLoratadine
    0363-0754Wal-itinLORATADINE
    0363-1686WAL-ITINLORATADINE
    0363-9150Wal-itinLoratadine
    0363-2085Wal-itin Allergy ReliefLoratadine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.